Suppr超能文献

评估香港高血压或糖尿病或两者并存患者的 EQ-5D-5L 效用评分的最小重要差异:一项横断面研究。

Estimation of minimally important difference of the EQ-5D-5L utility scores among patients with either hypertension or diabetes or both: a cross-sectional study in Hong Kong.

机构信息

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

BMJ Open. 2020 Nov 26;10(11):e039397. doi: 10.1136/bmjopen-2020-039397.

Abstract

OBJECTIVE

To estimate and report the minimally important difference (MID) of the EuroQol five-dimensional five-level questionnaire (EQ-5D-5L) using the Hong Kong (HK) utility score among patients with either hypertension or diabetes or both.

DESIGN

Data were analysed using secondary data analysis based on a cross-sectional study assessing patients' experiences in HK.

SETTING

A representative sample was recruited from 26 specialist outpatient clinics in HK.

PARTICIPANTS

We analysed data from 2231 and 662 patients who reported having hypertension or diabetes alone, respectively, and 874 patients had these two diseases.

INTERVENTION

An instrument-defined approach was applied to estimate MID stratified according to sex and age for the three subpopulations.

RESULTS

The overall MID (oMID) estimates were 0.089, 0.086 and 0.089 for patients with hypertension or diabetes alone and with these two diseases, respectively. The adjusted MID (aMID) estimate was smaller than the oMID, and the improved MID was larger than the deteriorated MID. Women had larger oMID but smaller aMID than men. Younger respondents had larger aMID than older respondents. Effect sizes ranged from 0.30 to 0.503, which fit our preset criteria.

CONCLUSION

Four types of MID of the EQ-5D utility score for patients with hypertension or diabetes alone and with these two diseases were reported. Variations in the MID estimates should be further explored in other populations or using different statistical methods.

摘要

目的

使用香港(HK)效用得分估计并报告欧洲五维健康量表五维问卷(EQ-5D-5L)在患有高血压或糖尿病或两者兼有患者中的最小重要差异(MID)。

设计

使用基于横断面研究评估患者在香港经历的二次数据分析数据。

设置

从香港 26 个专科门诊招募了一个代表性样本。

参与者

我们分析了分别报告患有高血压或糖尿病或同时患有这两种疾病的 2231 名和 662 名患者的数据,以及 874 名患有这两种疾病的患者的数据。

干预

根据三个亚组的性别和年龄,应用仪器定义方法估计 MID。

结果

患有高血压或糖尿病或同时患有这两种疾病的患者的总体 MID(oMID)估计值分别为 0.089、0.086 和 0.089。调整后的 MID(aMID)估计值小于 oMID,改善的 MID 大于恶化的 MID。女性的 oMID 大于男性,但 aMID 小于男性。年轻的受访者比年长的受访者有更大的 aMID。效应大小范围从 0.30 到 0.503,符合我们的预设标准。

结论

报告了单独患有高血压或糖尿病或同时患有这两种疾病的患者的 EQ-5D 效用评分的四种类型的 MID。应在其他人群或使用不同的统计方法中进一步探索 MID 估计值的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37d9/7692985/7088e5f01f23/bmjopen-2020-039397f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验